Patients on benralizumab, dupilumab, or mepolizumab have lower post-vaccination SARS-CoV-2 immunityArticle Published on 2024-06-012024-09-05 Journal: The Journal of Allergy and Clinical Immunology [Category] update2024, [키워드] Antibody neutralization Asthma biologics benralizumab COVID-19 Dupilumab memory B cells memory T cells mepolizumab mRNA vaccines SARS-CoV-2 [DOI] 10.1016/j.jaci.2024.03.029 PMC 바로가기 [Article Type] Article
Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significanceReview Article Published on 2024-03-212024-09-05 Journal: Allergologie Select [Category] update2024, [키워드] allergic rhinitis Asthma benralizumab Biologicals CRSwNP eosinophils mepolizumab mucositis reslizumab [DOI] 10.5414/ALX02469E PMC 바로가기 [Article Type] Review Article
Unanswered questions on the use of biologics in pediatric asthmaReview Published on 2023-11-032024-09-04 Journal: The World Allergy Organization Journal [Category] 대상포진, [키워드] benralizumab biologics Dupilumab mepolizumab omalizumab Severe childhood asthma Tezepelumab [DOI] 10.1016/j.waojou.2023.100837 PMC 바로가기 [Article Type] Review
SARS-Cov-2 Infection in Severe Asthma Patients Treated With BiologicsArticle Published on 2022-10-012022-11-15 Journal: The journal of allergy and clinical immunology. In [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome administration Admission adverse outcome asked Asthma benralizumab biologic biologics characterized Cohort coronavirus coronavirus disease COVID-19 COVID-19 pandemic Deterioration died disease severity Exacerbation female General population Greece hospital infected patients Infection initial mechanical ventilation mepolizumab observé omalizumab outcome pandemic Patient patients treated physician polymerase chain provided required risk SARS-CoV-2 SARS-COV-2 infection Severe asthma severe COVID-19 severity systemic corticosteroids therapy treated Treatment was performed [DOI] 10.1016/j.jaip.2022.05.041 PMC 바로가기
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemicArticle Published on 2022-08-012022-11-15 Journal: Respiratory medicine [Category] COVID19(2023년), SARS, 진단, [키워드] addition Affect Anxiety Asthma asthma patient Asthmatic patients benralizumab biologic Biological biological drug clinical disease Comorbidity decrease Depression depressive symptom disease drug evaluate female General population HADS Hypothesis independent males management Mental disorder mepolizumab monoclonal antibodies omalizumab pandemic parameters Patient patients treated Perceived stress Prevalence previous study problem PSS Psychiatric psychiatric disorder Psychological psychological disorders Psychological distress Quality of life reported Respiratory disease risk SARS-CoV-2 SARS-CoV-2 pandemic Severe asthma Stress treated Treatment [DOI] 10.1016/j.rmed.2022.106916 PMC 바로가기
COVID-19 in a Patient With Severe Eosinophilic Asthma on Benralizumab Therapy: A Case Report and Review of LiteratureAllergy/Immunology Published on 2021-12-232022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome addition Affect antiviral activity Asthma Asymptomatic COVID-19 benralizumab clinical status contribute coronavirus coronavirus disease Course COVID-19 COVID-19 patients COVID-19 prognosis cytotoxicity deplete Deterioration develop eosinophil Eosinophilic functions IL-5 immunoregulation Infection inflammatory reaction literature literature review modulation monoclonal antibody Patient positive report review SARS-CoV-2 Severe asthma severity of COVID-19 tested the disease therapy [DOI] 10.7759/cureus.20644 PMC 바로가기 [Article Type] Allergy/Immunology
Benralizumab for severe DRESS in two COVID-19 patients2명의 COVID-19 환자에서 중증 DRESS에 대한 BenralizumabCase Reports Published on 2021-01-012022-09-12 Journal: The journal of allergy and clinical immunology. In [Category] MERS, SARS, 진단, [키워드] benralizumab two COVID-19 patient [DOI] 10.1016/j.jaip.2020.09.039 PMC 바로가기 [Article Type] Case Reports
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic Position paper of Ärzteverband Deutscher Allergologen (AeDA) , Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) , Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA) , Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI) , Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI) , Österreichische Gesellschaft für Pneumologie (ÖGP) in co-operation with the German, Austrian, and Swiss ARIA groups , and the European Academy of Allergy and Clinical Immunology (EAACI)Research Article Published on 2020-09-072022-10-28 Journal: Allergologie Select [Category] COVID-19, [키워드] Academy Affect allergic allergic disease analyzed atopic atopic dermatitis benefit benralizumab bronchial asthma Care carried clinical collected complex Course courses COVID-19 COVID-19 pandemic Cytokine storm decrease develop disease disease course drastic Dupilumab early phase Effect European Evidence group immune reaction immune reactions immune response immunological increased risk Infection infection risk infection with SARS-CoV-2 inflammatory disease inhibit Interaction involved lack later phase maintain material mechanisms mepolizumab monoclonal antibodies nasal offer omalizumab pandemic Patient patients patients treated position positive potential risk provide question recommendation reslizumab risk Safe SARS-CoV-2 SARS-COV-2 infection selective severe COVID-19 Telemedicine the patient therapy These data Treatment [DOI] 10.5414/ALX02166E PMC 바로가기 [Article Type] Research Article
Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumabarticle Published on 2019-06-302024-09-01 Journal: International Journal of Chronic Obstructive Pulmonary Disease [Category] 폐렴구균 감염증, [키워드] bacterial load benralizumab COPD H. influenzae IL-5 S. pneumoniae [Article Type] article
Adverse events of benralizumab in moderate to severe eosinophilic asthma A meta-analysisarticle Published on 2019-05-312024-09-02 Journal: Molecular biology of the cell [Category] 대상포진, [키워드] adverse events anti-interleukin-5 benralizumab eosinophilic asthma Meta-analysis receptor α monoclonal antibody [DOI] 10.1097/MD.0000000000015868 PMC 바로가기 [Article Type] article